The Effects of Cannabis on Visual Functions in Healthy and Retinitis Pigmentosa Patients

NCT03078309 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-02-12

No results posted yet for this study

Summary

Medical Marijuana is used widely, and its effects on the visual system and the function of the retina have not been investigated thoroughly. Some evidence suggests that cannabinoids may be beneficial in certain degenerative diseases of the retina.

The purpose of the study is

1. To determine whether cannabis derivatives affect the visual functions in healthy adults
2. To examine the effect of cannabis derivatives on the retina of retinitis pigmentosa patients

Conditions

Interventions

DRUG

cannabis

single dose sublingual cannabis (THC:CBD 1:1, THC:CBD 1:40)

Sponsors & Collaborators

  • Hebrew University of Jerusalem

    collaborator OTHER
  • Hadassah Medical Organization

    lead OTHER

Principal Investigators

  • Hadas Mechoulam, MD · Hadassah Medical Organization

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03078309 on ClinicalTrials.gov